AT

Arjun Thekadavan

Active Director Director DIN 09775049
DIN 09775049 First appointment Oct 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Arjun Thekadavan

Data last updated:

Arjun Thekadavan is a Director at Medan Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Medan Pharmaceuticals Private Limited reported revenue of ₹1.72 Cr (FY 2025).

DIN 09775049
Primary Designation Director
Industry Pharma
First Appointment 26 Oct 2022
Oldest Company Age 12 yrs
Largest company Medan Pharmaceuticals Private Limited · ₹1.72 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Oct 20222013₹1.72 Cr (FY 2025)Active

Board colleagues of Arjun Thekadavan

Directorship timeline

Open interactive timeline →
Medan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arjun Thekadavan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arjun Thekadavan

Arjun Thekadavan currently holds 1 directorship: Medan Pharmaceuticals Private Limited (Director, since 26 Oct 2022, revenue ₹1.72 Cr (FY 2025)).

Arjun Thekadavan was first appointed on 26 Oct 2022 as Director at Medan Pharmaceuticals Private Limited.

The current boards of Arjun Thekadavan's companies include Deepa Pattuvanmar Veetil (Medan Pharmaceuticals Private Limited), Kalla Veedu Nidhin (Medan Pharmaceuticals Private Limited), Vipin Pattuvanmar Veedu (Medan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available